StageZero Life Sciences
  • About
    • Our Science >
      • The Sentinel Principle
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle-Test
  • COVID-19 Testing
    • COVID-19 Travel Solutions
    • Return-to-Work
    • Return-to-Learn
    • COVID-19-ONSITE-TESTING
    • TESTS >
      • Covid-19-PCR
      • Covid-19-Antibody
      • Respiratory Panel + COVID-19
    • Frequently Asked Questions
  • Physicians
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment
We Are Passionate About Our Mission to Reduce the Incidence of Late Stage Cancer 
​

​
Our next-generation test, Aristotle™, is a panel for simultaneously screening for multiple cancers from a single blood sample. Aristotle was recently selected for online publication at the 2020 annual meeting of the American Society of Clinical Oncology. 
​

​(TSX:SZLS)
Follow Us on Social Media!
Stock Chart
​Press Releases
SEDAR Filings
​Corporate Governance

Shareholder Information
Events

Investor Relations

We are ​StageZero Life Sciences (TSX: SZLS) and we are dedicated to finding cancer in the earliest stages when it is most curable. Our next-generation test, Aristotle™, is a panel for simultaneously screening for multiple cancers from a single blood sample.  Aristotle has been built on the company's mRNA Sentinel Principle Technology Platform, which was used to develop one of the first commercially available blood tests for Colorectal Cancer, ColonSentry®.

StageZero Life Sciences Q3 Earnings Call / Presentation

In The News

StageZero Life Sciences was recently featured on BNN Bloomberg.

© 2021 [http://www.B-TV.com%3c/a]www.B-TV.com. All Rights Reserved.


Press Releases

Investor Relations Contacts
James R. Howard-Tripp 
Chairman and CEO
jht@stagezerols.com

Rebecca Greco
Investor Relations

rgreco@stagezerols.com 
​1-855-420-7140 ext 1838

Corporate Headquarters
​30-70 East Beaver Creek Road

Richmond Hill, ON L4B 3B2

contact@stagezerols.com

Stay In Touch! Subscribe to Our Investor Updates

Picture
StageZero Life Sciences. Ltd.
​30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2

StageZero Life Sciences, Inc.
​8751 Park Central Drive, Suite 200
Richmond, VA 23227
​TEL: 855.420.7140 
Contact Information

Notice of Privacy Practices | Terms & Conditions | Privacy Statement & Policy | Licensing & Accreditation
  • About
    • Our Science >
      • The Sentinel Principle
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle-Test
  • COVID-19 Testing
    • COVID-19 Travel Solutions
    • Return-to-Work
    • Return-to-Learn
    • COVID-19-ONSITE-TESTING
    • TESTS >
      • Covid-19-PCR
      • Covid-19-Antibody
      • Respiratory Panel + COVID-19
    • Frequently Asked Questions
  • Physicians
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment